Age Management Medicine Group > Archives > April 2014 > April 2014 Agenda
       
HOME CONFERENCES CERTIFICATION TRAINING E-JOURNAL SPONSORS ABOUT

Agenda April 2014




  • Track 1
  • Track 2
  • Friday
  • Saturday
  • Sunday
  •  

    Pre-Conference Track 1: Obesity and Weight Loss for the Age Management Clinician
    7:00 AM - 7:45 AM
    How to Treat Sarcopenia in an Age Management Medicine Practice
    Presented by George C. Shapiro, M.D., Robert J. Hariri, M.D., Ph.D., Louis J. Aronne, M.D., and Robert Ashton, M.D.
    Non-CME symposium sponsored by Cenegenics Muscle Formula
    Open to all attendees and includes a complimentary breakfast
    8:00 AM - 9:00 AM
    Managing the High BMI Patient - A Practical Evidence-Based Review of the Toolbox
    Pankaj Vij, M.D., FACP
    Medical Director, Kaiser Medical Weight Management Program, Pleasanton, CA
    Lecture Description:
    Obesity and its accompanying chronic diseases account for the majority of the causes of morbidity and mortality in the US, as well as the majority of our soaring health expenditure. This presentation will provide the listener with the most effective evidence-based approach for communicating with the high BMI patient as well as practical tools for managing obesity, covering the whole gamut: ranging from communication skills related to lifestyle coaching, motivational interviewing, and the evidence behind and indications for prescription medications or Bariatric surgery. It will provide a clear understanding of the available tools and resources that can be applied to clinical practice right away. It will boost the clinician's confidence in managing weight related issues and provide them with a proven strategy that works in creating successful life transformation.
    9:00 AM - 10:00 AM
    The Impact of Obesity on the Cardiovascular System – Comparison of Patients Undergoing Lifestyle Changes with Obesity-Related Heart Disease
    Ernst R. Schwarz, M.D., Ph.D.
    Professor of Medicine, Cedars Sinai Medical Center at UCLA
    Lecture Description:
    Obesity represents a major problem in medicine. The AMA has recently recognized obesity as a disease, which enables us to more properly manage obese patients by use of medical science, drug treatment, and enforcing lifestyle changes. Besides being a factor in the cumulative risk with metabolic syndrome for the occurrence and progression of atherosclerosis, sexual dysfunction and coronary artery disease, obesity itself is considered a risk factor for the development of heart failure. Moreover, the clinical entity of obesity cardiomyopathy has recently gained more attention. We evaluated two groups of obese patients, one with overt cardiovascular disease (n=10) and one without but undergoing an age management program in order to optimize weight reduction efforts (n=50). The short and midterm outcomes of both groups are presented and compared.
    10:00 AM - 10:15 AM
    Break
    10:15 AM - 11:00 AM
    Cracking the Bikini Code - Secrets to Weight Loss Success: Part I - Etiology and An Effective and Innovative 4-Domain Treatment Strategy
    Kyrin Dunston, M.D., FACOG
    President & Medical Director, True Balance MD, Savannah, GA
    Lecture Description:
    Obesity and its secondary health disorders are at epidemic levels in the United States and have contributed substantially to the increase in morbidity and mortality rates of recent years. Etiology will be addressed including contributing factors such as poor dietary choices, sedentary lifestyle, general lack of effective treatment strategies and poor self-directed motivation of individuals to address these concerns. In treating people with weight loss resistance we are keenly aware of the primary major medical and biochemical issues that exist and must be addressed to achieve successful and lasting weight loss. These include hormonal balancing of insulin, cortisol and thyroid as well as the sex hormones and correction of any nutritional deficiencies and toxicities, or inflammatory issues, that exist. In this model excess adipose tissue is seen as a symptom of underlying imbalances and not the main issue itself. If the underlying imbalances are addressed successfully then not only will it result in weight loss naturally but also in achievement of health optimization. A successful program of weight loss is detailed that addresses the underlying imbalances present that contribute to this epidemic. Successful addressing of these four issues can be accomplished with a 4-pronged approach using natural measures including vitamins, minerals and herbs combined with a specific dietary regimen in almost all adults. More specific and dramatic results can be obtained with customized testing of each individual’s specific imbalances in each of these four domains including hormones, toxicity, nutritional deficiency and mental, emotional and spiritual health. Detailed as follows: Domain 1: proper salivary hormone testing of not only the sex hormones but also cortisol and melatonin. Thyroid and insulin hormone evaluation with optimal health normative levels is key to proper management of this highly prevalent condition of hypothyroidism. Domain 2: Toxicity status is discovered by addressing the main sources of inflammation and therefore internal toxic chemical production by occult gastrointestinal infections with yeasts and parasites and pathogenic bacteria as well as hidden food sensitivities. Elimination of iatrogenic chemical overuse is also addressed by removing offending ingestion of chemicals (dermal, oral and respiratory) and stimulating all phases of liver and gastrointestinal detoxification. Domain 3: Nutritional deficiencies are identified with comprehensive nutritional testing to include fat and water-soluble vitamin status, mineral status, fatty acid, amino acid and organic acid status allowing for targeted and customized nutritional supplementation to address the patients unique deficiencies. IV therapies are used as indicated. Domain 4: Mental, emotional and spiritual health must be addressed with a comprehensive program to uncover the maladaptive strategies each patient has deve developed that contribute to self-sabotaging behaviors and introduction of effective tools for behavior modification. This revolutionary 4-domain approach to overweight and obesity that addresses the symptom of excess adiposity by targeting the biochemical imbalances existing on a cellular and systems level is an effective and comprehensive approach that is safe and effective for most adults. It is easily integrated into most medical practices as a cost effective tool to combat this pervasive disease.
    11:00 AM - 12:00 PM
    Cracking the Bikini Code - Secrets to Weight Loss Success: Part 2 - Overcoming Weight Loss Resistance Due to Self-Sabotage: A Novel and Effective Approach
    Kyrin Dunston, M.D., FACOG
    President & Medical Director, True Balance MD, Savannah, GA
    Lecture Description:
    Obesity and its secondary health disorders are at epidemic levels in the United States and have contributed substantially to the increase in morbidity and mortality rates of recent years. Effective and permanent weight loss methods have provided dismal results with most programs leading to only 6% successful weight loss at one year. This weight loss resistance is rampant in the United States, within our practices and among our patients. Self-sabotage is a primary obstacle thwarting successful weight loss and must be addressed to achieve significant progress in halting this lethal disorder. In treating people with weight loss resistance we are keenly aware of the primary major medical and biochemical issues that must be addressed to achieve successful and lasting weight loss. These include hormonal balancing of insulin, cortisol and thyroid as well as the sex hormones and correction of any nutritional deficiencies and toxicities, or inflammatory issues, that exist. Management of these factors has been detailed extensively elsewhere and will not be the focus of this discussion. If patients are able to follow a comprehensive functional medicine program that addresses these underlying issues then successful weight loss is assured. But in reality self-sabotage generally prevents this in most cases. A successful and novel approach to addressing self-sabotage is the use of a technology called transformative coaching. In direct opposition to traditional, or directive, coaching, this particular type of coaching utilizes the science of metaphysics and the power of intention to direct the outcome of a given treatment regimen towards the desired result. Metaphysicists have clearly demonstrated that the intention of an observer changes the outcome of an experiment or treatment. Having patients concretely outline their intended outcome at the beginning of treatment significantly assists them in successfully achieving those results. This novel approach gains further validity by addressing all aspects of a person’s life; finances, relationships, career, creativity, fun, free time and spirituality. Studies have repeatedly shown that health challenges are directly proportional to challenges in these other areas of quality of life measures. With visioning there is an increased likelihood that their health will improve along with other parameters in their life. The defined path for health improvement is followed more easily and results are achieved more rapidly as well. The specific technologies of metaphysics, visioning and transformative coaching provide a novel and effective approach to combatting weight loss resistance due to self-sabotage. This talk defines the science behind this useful technology as well as the practical integration of these tools into every day practice.
    12:00 PM - 1:30 PM
    Lunch Break
    12:00 PM - 1:00 PM
    Lengthening Telomeres Safely with TA-65: Case Studies from the Clinic
    Presented by Harvey S. Bartnof, M.D.
    Non-CME symposium sponsored by T.A. Sciences
    Open to all attendees and includes a complimentary lunch
    1:30 PM - 2:15 PM
    Update on Metabolic Syndrome with Emphasis on Gender Differences
    Ellie W. Campbell, D.O.
    Board Certified, American Academy of Family Medicine and American Board of Integrative and Holistic Medicine
    Medical Director and CEO, Campbell Family Medicine, Suwanee, GA
    Board Member, International Academy of Functional Neurology and Rehabilitation
    Lecture Description:
    Attendees can expect to gain understanding of the varying parameters for defining Metabolic Syndrome used by international expert panels. They will be able to express understanding of the clinical implications for increased risk of Alzheimer’s disease, coronary heart disease, diabetes, fatty liver, and several cancers. They will recognize some biopsychosocial gender differences in presentation and treatment, and identify several treatment strategies that include prescription medications and evidence-based dietary interventions and integrative/alternative treatments.
    2:15 PM - 3:05 PM
    Hormonal Effects Contributing to Weight (or FAT) Loss Resistance
    Rebecca R. Murray, APRN, FNP-BC, CDE
    Endocrine Nurse Practitioner, Institute for Hormonal Balance, Orlando, FL
    Medical Director, Ward-Murray HealthCare Consulting, Groton, CT
    Scientific Advisory Board, Designs for Health
    Lecture Description:
    With the rising epidemic of obesity and the associated disease related co-morbidities, most medical practitioners are at a loss as to how to approach this major problem. They have come to realize that the old accepted phrases of: “eat 500 calories less a day and you will lose a pound a week” along with “a calorie is a calorie is a calorie” are not true. New pharmacologic agents aimed at weight loss have either failed in most people or caused more grievous side effects. Giving credit to the outstanding work of Roger Williams in regard to “Biochemical Individuality,” this lecture will focus on the role of hormones and psychoneuroendocrinology as it relates to the intricacies of an individual’s “gene-environment interaction” and the effects on “FAT” loss resistance.
    2:30 PM - 7:00 PM
    Exhibits Open
    3:05 PM - 3:50 PM
    Break - Visit Exhibits
    3:50 PM - 4:40 PM
    The Hidden Causes of Metabolic Syndrome and Type 2 Diabetes: How to Evaluate Those Patients Who Are Doing Everything Right and Still Have Problems
    Thomas Alexander, M.D.
    Director of Clinical Support Services, Cyrex Laboratories, Phoenix, AZ
    Lecture Description:
    Metabolic Syndrome (MS) and Type 2 Diabetes (T2DM) have been classically seen as disorders triggered by poor eating and lack of exercise. In the last few years other contributing mechanisms of dysfunction in Metabolic Syndrome have become increasingly clear. This lecture is going to review the causes of MS and T2DM beyond the conventionally studied ones and offer treatment approaches beyond just diet and exercise. Metabolic Endotoxemia and Systemic Lipopolysaccharides (LPS), the role of toxins in Metabolic Syndrome and Diabetes Type 1.5 are discussed.
    4:40 PM - 5:30 PM
    Polycystic Ovarian Disease and Obesity
    Erika Schwartz, M.D.
    Member, Board of Trustees and Managers, SUNY-Downstate College of Medicine, Brooklyn, NY
    President, Evolved Science
    Lecture Description:
    While obesity is the most common health problem in the US, 50% of women with polycystic ovary syndrome (PCOs) are thought to be obese. (1) Although, the syndrome is now recognized to occur in both lean and obese women, women with PCOs who are obese may have risks for associated comorbidities that are additive when compared to their non-obese counterparts with PCOs or obese women without PCOs. (2) The prevalence of obesity in PCOs may be influenced by diagnostic criteria, geographic and environmental factors as well as genetics. There is no known unique reason for the prevalence of obesity in PCO patients. Various forms of obesity are found in women with PCOs as well as the general population. However, the most studied are those with android or central obesity. These women with central obesity and PCOs have decreased glucose tolerance and hyperinsulinemia in premenopausal stage. (3) Women with PCOs and central obesity also seem to have higher androgen, glucose, lipid levels as well as increase in diastolic blood pressure when compared to women with peripheral fat distribution. (4) There has been some debate in the literature about whether women are obese because of their PCOs status or if those who become obese are more predisposed to PCOs. Most of the data however lean towards similar outcomes with weight reduction and lifestyle recommendations in women with and without PCOs. (5) A review of studies on weight loss in obese women with PCOs and data on PCOs outcomes associated with the weight loss is provided.

    5:30 PM - 7:00 PM
    AMMG Welcome Reception
    Held in Conference Networking and Exhibits Center
    Open to all conference attendees, spouses and guests



  • Track 1
  • Track 2
  • Friday
  • Saturday
  • Sunday
  •  

    Pre-Conference Track 2: Introduction to Age Management Medicine; How to Integrate Nutrition, Supplements, Hormones, Fitness, Prevention and Early Detection of Disorders of Aging, Telomere, Stem Cells, and Genetics Into Your Clinical Practice
    7:00 AM - 7:45 AM
    How to Treat Sarcopenia in an Age Management Medicine Practice
    Presented by George C. Shapiro, M.D., Robert J. Hariri, M.D., Ph.D., Louis J. Aronne, M.D., and Robert Ashton, M.D.
    Non-CME symposium sponsored by Cenegenics Muscle Formula
    Open to all attendees and includes a complimentary breakfast
    8:00 AM - 8:50 AM
    Nutrient Strategies for the Age Management Clinician
    Derrick M. DeSilva, Jr., M.D.
    Chairman, AMMG Conference Planning Committee
    Senior Attending Staff, Dept. of Medicine, Raritan Bay Medical Center, Perth Amboy, NJ
    Teaching Faculty, JFK Medical Center, Edison, NJ
    Lecture Description:
    Basic nutrients are critical to better health. The safe use of these nutrients in clinical practice is even more critical. How clinicians inform their patients on the safe use of these supplements needs to be part of their daily routine. During this presentation we will review some of the basic strategies the physician can use to make patients in their practice, and the public in general, aware that what they are doing is not only beneficial but safe.
    8:50 AM - 9:40 AM
    Clinical Use of Supplements in the Age Management Practice
    Derrick M. DeSilva, Jr., M.D.
    Chairman, AMMG Conference Planning Committee
    Senior Attending Staff, Dept. of Medicine, Raritan Bay Medical Center, Perth Amboy, NJ
    Teaching Faculty, JFK Medical Center, Edison, NJ
    Lecture Description:
    Estimates are that 70% of the U.S. population is using some type of “Integrative Medicine”. Supplement use by our patients is above 50%. During the presentation we will discuss the safe and best way for the clinician to direct their patients on the use of supplements.
    9:40 AM - 10:25 AM
    The Science of Genetics and Genetic Testing and Age Management Medicine
    Florence Comite, M.D.
    CEO & Founder, Comite Center for Precision Medicine, New York, NY
    Member, AMMG Conference Planning Committee
    Lecture Description:
    Genetic screening is increasingly available; it is a natural extension of Age Management Medicine. Obtaining the genetic make-up of individuals can help to identify potential disorders of aging. However, the genetic blueprint is not absolute, nor is it a predestined outcome. Since this is rapidly being actualized in practice, the clinician should be comfortable with the interpretation of genetic testing and the value of diagnostic screening. Patients deserve a solid understanding of the relationship between their genes and disorders of aging. It is vital that the clinician is prepared to balance, discuss, and position the possible outcomes in relaying test results. Overall, screening adds much to our ability to identify underlying influences that might tilt the scales toward various disorders of aging. At the same time, it strengthens our ability to manage and motivate successfully. Further, it allows the clinician to set interventional priorities and weigh the risk-benefit scale of options. This leads to more precise guidance with respect to subsequent diagnostic tests and procedures as well as interventions, ranging from lifestyle to supplements and medications.
    10:25 AM - 10:40 AM
    Break
    10:40 AM - 11:30 AM
    The Use of Fitness in the Clinical Age Management Practice: Assessing the Patient and Developing Individualized Treatment Plans
    Shahab Mokhtare, M.D.
    Partner, Cenegenics, Las Vegas, NV
    Lecture Description:
    A systematic review of the effects of customized training interventions on measures of functional outcomes in healthy older adults. The importance of assessing the patient, categorizing them based on strength and cardiovascular ability, and developing an individualized treatment plan will be reviewed. We will further analyze a case study of a 49-year-old former natural competitive body builder who presented with visceral adiposity, joint pains, decreased energy and diminished libido.
    11:30 AM - 12:00 PM
    The Science of Telomere and Age Management
    Earl H. Eye, M.D., FACCP
    President, Cenegenics, Jacksonville, FL
    Lecture Description:
    Learn what telomeres are, how they function, what association they have with disease, how to detect shortening, and potential interventions. I will present a case of a 51-year-old white female who is very compliant with our program and had virtually perfect labs except for a slight insulin elevation. She will illustrate why testing is important. I will discuss (1) what we can do to discover short telomeres, and (2) measures to lengthen short telomeres.
    12:00 PM - 1:30 PM
    Lunch Break
    12:00 PM - 1:00 PM
    Lengthening Telomeres Safely with TA-65: Case Studies from the Clinic
    Presented by Harvey S. Bartnof, M.D.
    Non-CME symposium sponsored by T.A. Sciences
    Open to all attendees and includes a complimentary lunch
    1:30 PM - 2:30 PM
    Introduction to HRT in Women and Female Sexual Health
    Anna Cabeca, D.O., FACOG, ABAARM
    Medical Director, Vida Pura Health, Golden Isles Medical, Inc., St. Simons Island, GA
    Lecture Description:
    Sexual health is a crucial factor in female health at any age, especially in the perimenopause and menopause and is significantly affected by hormonal balance and is a significant factor in the health of relationships. In this lecture, hormonal changes that lead to loss of libido, vulvar and vaginal disorders will be reviewed. Clinical therapeutic interventions, both hormonal and non-hormonal, will be discussed. These therapies have a positive impact on sexual health. More research is recommended to document the efficacy, dosage, and duration of treatment of vaginal hormone therapies.
    2:30 PM - 7:00 PM
    Exhibits Open
    2:30 PM - 3:30 PM
    Introduction to HRT in Men
    Joseph Bosiljevac, M.D., Ph.D., FACS
    Senior Partner, Cenegenics, New York, NY
    Lecture Description:
    This presentation is based on a review of hormone replacement therapy in men. Take the concept of a “human machine”; if you balance the machine chemically and hormonally it will function as it did years ago. That is the key to prolonging health and longevity. This is more than looking at so-called normal levels we were taught in conventional medicine but a “hormone orchestra” rather than individual levels. The important aspect is to define the level for optimal functioning of each individual patient and not using a cookbook approach.
    3:30 PM - 4:15 PM
    Break - Visit Exhibits
    4:15 PM - 4:45 PM
    The Science of Stem Cells and Age Management Medicine
    Christopher Centeno, M.D.
    Medical Director, Centeno-Schultz Clinic, Broomfield, CO
    Member, AMMG Conference Planning Committee
    Lecture Description:
    Recent research has implicated that adult stem cells play a role in aging. Other research has shown that aging can negatively impact the health of adult stem cells. Various strategies to revive aged adult stem cells will be presented.
    4:45 PM - 5:30 PM
    Assessing the Age Management Patient
    C.B. Daniel, M.D.
    CEO & CMO, Cenegenics, Phoenix, AZ
    Lecture Description:
    What is the current evidence based approach to the initial clinical assessment of the age management patient? How has the clinical evaluation evolved over the last several years and where is it headed in the future? What are the current diagnostic tools we have available to evaluate and to monitor patients in age management medicine? What is our relationship to our traditionally practicing medical colleagues? How do we understand what our roles and responsibilities are to our patients in age management medicine?
    5:30 PM - 7:00 PM
    AMMG Welcome Reception
    Held in Conference Networking & Exhibits Center
    Open to all conference attendees, spouses and guests



  • Track 1
  • Track 2
  • Friday
  • Saturday
  • Sunday
  •  

    Friday, April 25th General Session Curriculum
    7:00 AM - 7:45 AM
    Medical Literature That Challenges Your Current Treatment Regimes
    Presented by Neil Rouzier, M.D.
    Non-CME symposium sponsored by MedQuest Pharmacy
    Open to all attendees and includes a complimentary breakfast
    8:00 AM - 8:05 AM
    Opening Remarks
    Derrick M. DeSilva, Jr., M.D.
    Chairman, AMMG Conference Planning Committee
    Senior Attending Staff, Dept. of Medicine, Raritan Bay Medical Center, Perth Amboy, NJ
    Teaching Faculty, JFK Medical Center, Edison, NJ
    8:05 AM - 9:00 AM
    Keynote Presentation – Testosterone Therapy in Men: Panacea, Scourge, or Simply the Next Big Thing in Medicine?
    Abraham Morgentaler, M.D., FACS
    Director, Men’s Health Boston, Boston, MA
    Associate Clinical Professor of Urology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA
    Lecture Description:
    This lecture will provide a look backward, forward, and an overall big picture perspective on testosterone therapy in men, providing information on the epidemiology and natural history of testosterone deficiency, its symptoms and signs, how to diagnose it, and how to treat. Major concerns in testosterone therapy will be addressed, including prostate cancer and the hotly debated new issue of cardiovascular risk. Dr. Morgentaler will share his personal views on this highly controversial topic.
    9:00 AM - 10:00 AM
    The Truth About Statins
    Derrick M. DeSilva, Jr., M.D.
    Chairman, AMMG Conference Planning Committee
    Senior Attending Staff, Dept. of Medicine, Raritan Bay Medical Center, Perth Amboy, NJ
    Teaching Faculty, JFK Medical Center, Edison, NJ
    Lecture Description:
    Heart disease is still the #1 killer in this country. But is elevated cholesterol the real culprit or is it the scapegoat that has been invented to make the stockholders of big pharma happy? Approximately 35% of people that have a myocardial infarction have normal cholesterol levels yet most of them have atherosclerosis. This likely means that high levels of cholesterol are not always necessary for atherosclerotic plaques to form. So what is the real mechanism of the atherosclerotic plaque formation? Inflammation has to be part of this complex process. We also know about the numerous side effects of the HMG-Co reductase inhibitors including neurologic damage, increased risk of diabetes, increased risk of cataracts, myalgia, arthralgia, hepatic damage etc. So who is really a candidate for statin therapy? We will review the data on the real truth about stain therapy and what the studies really point to when it comes to the mechanism of atherosclerosis.
    10:00 AM - 10:45 AM
    Break - Visit Exhibits
    10:45 AM - 11:30 AM
    Treatment Registry Results of Stem Cell Injections in Orthopedics: Does Testosterone/Thyroid Supplementation Matter?
    Christopher Centeno, M.D.
    Medical Director, Centeno-Schultz Clinic, Broomfield, CO
    Member, AMMG Conference Planning Committee
    Lecture Description:
    Mesenchymal stem cells (MSCs) are present in many tissues and have the potential to assist in tissue repair. The author will present treatment registry data collected since 2005 on the use of MSCs in orthopedic injuries including shoulder arthritis, rotator cuff tears, ankle arthritis, knee arthritis, knee ACL tears, hip arthritis, and hand arthritis. In addition, the lecture will also include data concerning MSC activity (counts present in the bone marrow, proliferation, chondrogenesis) before and after a short course of testosterone/thyroid supplementation.
    11:30 AM - 12:15 PM
    To Test or Not to Test: The Use of Biological Markers and Laboratory-Based Testing in Clinical Psychiatric Syndromes
    David J. Scheiderer, M.D., MBA, DFAPA
    Private Practice, Psychiatry
    Former Assistant Clinical Professor, University of Virginia School of Medicine
    Lecture Description:
    Few clinical areas afford us as great an opportunity to advance the state of the art and science of Age Management Medicine as Psychiatry. For example, psychiatric syndromes rank among the most common, costly, and catastrophic conditions across all treatment settings. Depression alone is the most common cause of disability in North America. Moreover, as measured by Average Years of Life Lost (AYLL - Colton CW et al. Prev Chronic Dis. 2006;3:A42; Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2008 Nov 14;57(45):1226-8.), those who suffer from mental illness die on average 28 years before their time. And what kills them? Heart disease and metabolic syndrome just like the rest of us only decades earlier. Talk about acceleration of the aging process! At the same time, experts estimate that of all people who suffer from depression in any given 12 months, fewer than 25% receive even “minimally adequate” treatment. There are many reasons for this: diagnostic heterogeneity, the multi-factorial nature of psychiatric disorders, ineffective medications, and drug side effects. Moreover, there are no clinical laboratory tests to date that can be used by clinicians to diagnose patients with psychiatric disorders. There are, however, peripheral biomarkers available that can identify patients with pathophysiologic processes and serve to objectively monitor therapeutic responses within relevant pathways. As such, the goal of this presentation is to introduce the concept of pathophysiologic (as opposed to diagnostic)-specific testing panels to aid in the detection of mediators (hormones, neurotransmitters, growth factors, and immune factors) of psychiatric symptoms. This in turn will equip the conference participants to develop and implement strategies for employing currently available laboratory tests to generate individualized Age Management treatment interventions in order to improve clinical outcomes in patients with psychiatric disorders.
    12:15 PM - 1:30 PM
    Lunch Break - Visit Exhibits
    12:15 PM - 1:15 PM
    Physician Opportunities in Age Management Medicine: Your Path to a Successful Age Management Medicine Practice
    Presented by John E. Adams, President and CEO, Cenegenics
    Non-CME symposium sponsored by Cenegenics Elite Health
    Open to all attendees and includes a complimentary lunch
    1:30 PM - 2:15 PM
    Starving Cancer Cells to Death
    George W. Yu, M.D.
    Clinical Professor of Urological Surgery, Department of Urology, George Washington University Medical Center, Washington, DC
    Research Associate, Aegis Medical and Research Associates, Annapolis, MD
    Lecture Description:
    The research relating Caloric Restriction (CR) to longevity and cancer control will be presented with Dr. Yu’s own experience treating patients with CR combined with traditional therapy. In addition he will present the cutting-edge understanding of the metabolic approach to cancer research and treatments – deprivation of glucose (glycolysis) and use of metabolic analogues such as 3 Bromo Pyruvate (blocking mitochondrial function) in cancer cells. Both animal and human data will be discussed in this trend in cancer research and treatments using a nutritional and metabolic approach.
    2:15 PM - 3:00 PM
    Emerging Lifestyle Factors Predict Arterial Plaque Age and Arterial Plaque Regression
    Steven C. Masley, M.D., FAHA, FACN, FAAFP, CNS
    President, Masley Optimal Health Center, St. Petersburg, FL
    CEO, Heart Tune-Up, LLC
    Medical Director, Ten Years Younger Program™
    Clinical Assistant Professor, University of South Florida, Tampa, FL
    Special Program Instructor, Eckerd College and the University of Tampa
    Lecture Description:
    Cardiovascular disease remains the #1 cause of death in the western world, accounting for more than 34% of all deaths. Lifestyle changes are more effective than cardiac procedures in preventing future cardiovascular events. Dr. Masley will share data that he has submitted for publication related to his prospective cross-sectional analysis of >600 men and women. Measurements were made of body composition, anthropometric measures, fitness, diet (measured with a 3-day food diary), laboratory measures, and mean carotid IMT. The carotid intimal thickness was measured as a continuous variable, using both multivariate linear and bivariate linear regression. In this database, aerobic fitness and dietary intake of fiber, fish, magnesium, and zinc are associated with lower carotid IMT scores. Of the traditional CVD risk factors, only systolic blood pressure, fasting glucose, body composition, and total cholesterol/HDL ratio have an inverse relationship with mean carotid IMT. Further studies are warranted to explore the impact of emerging lifestyle factors on cardiovascular risk and clinical outcomes. Physicians need to know the most effective and appropriate recommendations for exercise and fitness testing, Dr. Masley’s new five categories of heart healthy foods, and evidence-based heart-friendly supplement recommendations that can complement lipid, metabolic, hormonal, and blood pressure therapy to optimize clinical outcomes for cardiovascular disease. Unfortunately, most physicians have had little if any formal training on these critical lifestyle recommendations. This presentation aims to narrow this gap, by sharing new, innovative, and cutting-edge data and therapy options developed from ongoing research.
    3:00 PM - 3:30 PM
    Break - Visit Exhibits
    3:30 PM - 4:20 PM
    Late Breaking Clinical Trial Results of Adipose Derived Stem Cells in Congestive Heart Failure: The ANGEL Trial
    Kristin Comella
    Chief Scientific Officer, Bioheart, Inc., Sunrise, FL
    Lecture Description:
    Late-Breaking Clinical Trials sessions are innovative and provide the latest breakthroughs in clinical science and potentially will have a significant impact on clinical practice. The field of regenerative medicine is rapidly growing with an emphasis on stem cell therapies and the promise of cures for everything from acute injuries to chronic degenerative diseases. The list of indications is expanding as more studies are published to demonstrate safety and efficacy. Regenerative medicine is the process of replacing or regenerating human cells, tissues or organs to restore or establish normal function. The concept is that damaged tissue can be restored by using the body’s own healing mechanism to promote repair. This new branch of medicine may change the course of chronic diseases and standard clinical therapies. This session will discuss the results of the ANGEL trial studying the safety and cardiovascular effects of intramyocardial implantation of autologous adipose-derived stem cells in patients with chronic ischemic cardiomyopathy.
    4:20 PM - 5:30 PM
    Protecting the Aging Brain: Functional Neurology for Better Balance, Memory and Cognition
    Ellie W. Campbell, D.O.
    Board Certified, American Academy of Family Medicine and American Board of Integrative and Holistic Medicine
    Medical Director and CEO, Campbell Family Medicine, Suwanee, GA
    Board Member, International Academy of Functional Neurology and Rehabilitation
    Lecture Description:
    Attendees will understand the emerging definition of Functional Neurology and apply its principles to improve function of the aging brain. Data on the morbidity and mortality of balance disorders with accompanying falls and fractures is compelling and much can be done to rehabilitate the brain. Attendees will learn balance assessment tools including the Get Up and Go test, as well as video nystagmography and The CAPS™ (Comprehensive Assessment of Postural Systems) test. Once vestibular dysfunction is identified, treatment protocols will be discussed for both the impaired vestibular ocular reflex and optokinetic nystagmus. Tools for the early identification of Memory and Cognitive Impairment will be reviewed. Attendees will learn to utilize objective assessments of cognition including the MMSE, clock drawing test, webNeuro, and SPECT imaging for mTBI and dementia (with SPECT abnormalities seen up to 10 years before cognitive decline). Treatments will be reviewed including functional rehab, physical exercise and brain games, binaural sound therapy and neuropsychological retraining, as well as diet and targeted nutritional supplementation.
    5:30 PM - 7:00 PM
    AMMG Networking Reception & Complimentary Raffle
    Held in Conference Networking & Exhibits Center
    Open to all conference attendees, spouses and guests



  • Track 1
  • Track 2
  • Friday
  • Saturday
  • Sunday
  •  

    Saturday, April 26th General Session Curriculum
    7:00 AM - 7:45 AM
    The Science of Secretagogues
    Presented by Mark Gordon, M.D.
    Non-CME symposium presented by University Specialty Drugs
    Open to all attendees and includes a complimentary breakfast
    8:00 AM - 8:50 AM
    Insulin Resistance
    Jeffry S. Life, M.D., Ph.D.
    Clinic Physician, Apeiron, Charleston, WV
    Board Certified, Family Medicine
    Diplomate, American Board of Family Practitioners
    Fellow, American Academy of Family Physicians
    Lecture Description:
    Presentation will discuss the cause and treatment of insulin resistance and the mechanisms that make it the root cause of our epidemic of premature death and disability.
    8:50 AM - 9:40 AM
    Why Men Fake It: A New Perspective on Men, Sex and Relationships
    Abraham Morgentaler, M.D., FACS
    Director, Men’s Health Boston, Boston, MA
    Associate Clinical Professor of Urology, Harvard Medical School, Beth Israel Deaconess Medical Center, Boston, MA
    Lecture Description:
    In this lecture Dr. Morgentaler will present a startlingly new perspective on male sexuality and how this impacts relationships based on his quarter-century of clinical practice. Talking to men behind closed doors and listening to their sexual needs and concerns provides a window into the male psyche that offers a surprisingly optimistic and sympathetic view of men.
    9:40 AM - 10:20 AM
    Break - Visit Exhibits
    10:20 AM - 11:15 AM
    A Literature Review of Importance of HRT in Preventing Breast Cancer
    Neal Rouzier, M.D.
    Director, The Preventive Medicine Clinics of the Desert, Palm Springs, CA
    Lecture Description:
    Recently a medical board brought charges against a physician for using micronized progesterone in a menopausal woman who had a hysterectomy and a very positive family history of breast cancer. Unbelievable, but true. Criticism was also voiced against the physician for utilizing testosterone in such a patient due to the fact that the baseline testosterone levels were normal (at 0.2pg/ml). The medical board expert testified that the treatment levels were too high and with hormones that were not indicated. Preposterous as it may seem, medical boards are intolerant to the use of bioidentical hormones, inappropriate internet claims, replacement to seemingly supraphysiologic replacement, and for off label use. This lecture will review the defense that I successfully used as well as the medical literature support for optimizing hormones for health and wellness that the medical board and medical expert were not aware of, much to their dismay and embarrassment. There is a plethora of data and studies in our literature for progesterone and testosterone that demonstrate protection against breast cancer, sexual dysfunction, PMS, perimenopause, depression, but only at high optimal levels.
    11:15 AM - 12:00 PM
    Estrogen Dominance
    Mark L. Gordon, M.D.
    Medical Director, Millennium-TBI & The Millennium Health Centers, Encino, CA; CBS Studios;
    USC, Keck School of Medicine, Department of Family Medicine, Los Angeles, CA
    Medical Director of Education, Access Medical Laboratories, Jupiter, FL
    Member, AMMG Conference Planning Committee
    Life Member, AMMG
    Lecture Description:
    The complexity of a woman’s hormonal life is frequently an intimidating dynamic process that keeps many of those not trained in gynecology unsteady. An appreciation of the maturational changes that occur in the hormonal flux of a woman can be used to modify or change the natural (not necessarily normal) progression of her hormones and improve upon her quality of life. Frequently, when estrogens are not balanced by progesterone, it can produce an acceleration of the aging process, increased allergies, including asthma, hives, rashes, sinus congestion, autoimmune disorders such as lupus erythematosis and thyroiditis, and possibly Sjoegren's disease, breast cancer, breast tenderness, fibrocystic disease of the breast, cervical dysplasia, incontinence, copper excess, decreased libido, depression with anxiety or agitation, dry eyes, endometrial cancer, fat gain (especially around the abdomen, hips and thighs), fatigue, cognitive impairment, gallbladder disease, hair loss, headaches, hypoglycemia, increased blood clotting, irritability, insomnia, magnesium deficiency, memory loss, mood swings, osteoporosis, polycystic ovaries, premenopausal bone loss, PMS, thyroid dysfunction mimicking hypothyroidism, uterine cancer, myometrial hyperplasia, fluid retention, bloating, and zinc deficiency. Not only has it been well established that estrogen dominance encourages the development of breast cancer thanks to estrogen's proliferative actions, it also stimulates breast tissue and can, in time, trigger fibrocystic breast disease as well as fibrocystic disease of the ovaries. By definition, excess estrogen implies a progesterone deficiency. This, in turn, leads to a decrease in the rate of new bone formation in a woman's body by the osteoblasts—the cells responsible for doing this job. Although most doctors are not yet aware of it, this is the prime cause of osteoporosis. Estrogen dominance increases the risk of fibroids (leiomyoma). One of the interesting facts about fibroids—often remarked on by doctors—is that, regardless of the size, fibroids commonly atrophy once menopause arrives and a woman's ovaries are no longer making estrogen. Doctors who commonly use progesterone with their patients have discovered that giving women natural progesterone will also cause fibroids to atrophy. This lecture will (1) address the knowledge of Estrogen Dominance and (2) how to modify it with the EP Ratio; a relational calculation between Estrone, Estradiol and Progesterone, and (2) treatment options with BHRT. Additionally, we will review Estrogen cancer prevention with natural products and a few cases of Estrogen Dominance.
    12:00 PM - 1:15 PM
    Lunch Break - Visit Exhibits
    12:00 PM - 1:00 PM
    ROEHR BioG MicroTabs: Personalized Nutrition in the 21st Century
    Presented by Wolfgang Roehr, CEO, ROEHR Pharmaceuticals, and Julian Blumenfeld, M.D., CMO, ROEHR Pharmaceuticals
    Non-CME symposium sponsored by ROEHR Pharmaceuticals
    Open to all attendees and includes a complimentary lunch
    1:15 PM - 2:05 PM
    Featured Speaker - Solving the Puzzle of Adrenal Fatigue: A 5-Point Framework: Hormones, Nutrients, Toxins, Mind and Body Balance
    Sangeeta Pati, M.D., FACOG
    Medical Director, SaJune Institute for Restorative and Regenerative Medicine, Orlando, FL
    Board Certified, American Board of Obstetrics and Gynecology
    Diplomat, Anti-Aging & Regenerative Medicine
    Lecture Description:
    As we age, hormone production and nutrient status decline. Hormone function is at about 50% by the age of 50. Absorption of B-12 declines naturally with age. Although this is still considered “normal” it is not “optimal.” The decline of hormones and nutrients results in a host of symptoms (including fatigue) and ultimately leads to degenerative diseases such as arthritis, heart attacks, high blood pressure, diabetes, osteoporosis and cancer. Correction of hormones and nutrients to “optimal” levels, removal of toxins and mind-body interventions generally correct energy levels back to normal.

    Why are we seeing more fatigue and adrenal compromise?
    With increasing frequency we are faced with the progression of fatigue to adrenal insufficiency and often adrenal failure. These are the people, of any age who come in with fatigue, achiness, insomnia, inflammation, hypersensitivity to everything, panic attacks and many more symptoms. These are the ones who end up with diagnoses such as fibromyalgia, anxiety disorder and early arthritis. As such, this has been appropriately called “The 21st Century Stress Syndrome” by Dr. James Wilson. At this point in history, we will rarely encounter the patient who has strong adrenal function because:
    We are depleting our hormones and nutrients faster as we live in a world where we are exposed to more stimulation of the nervous system. We are aware of conscious stimuli such as beeping phones, alerts, global news, social media, too many people and too many opportunities to interact; and often unaware of the subconscious stimuli such as electromagnetic fields and energies.
    We have low reserves to begin with. The USDA reports over 50% reduction in the nutrient content of our top 34 crops in the years 1959 to 1999. Studies support a steady decline in hormone levels over time in age-matched controls. One study has reported a 15% population decline in men’s testosterone levels from 1997 to 2004.
    What is “adrenal fatigue” or “adrenal burnout”?
    With the current levels of stress in daily life we are seeing more and more dysfunction of the adrenal gland. The body is programmed to respond to acute stressors with an acute stress response which includes elevation of cortisol, epinephrine, heart rate, blood pressure and general sympathetic nervous system response. When people are exposed to long periods of emotional or physical stress, the adrenal gland does not have the nutrients to produce a normal cortisol response. The adrenal gland then enters an insufficiency status (some call adrenal burnout) characterized initially by severe fatigue. As it progresses and cortisol levels decline, symptoms may include body pain, multiple sensitivities, allergies and difficulty dealing with normal life stressors. Other signs and symptoms of adrenal insufficiency may include:
    • Frequent flu
    • Afternoon slump
    • Frequent waking at night
    • Panic attacks
    • Dependency on coffee or stimulants for energy
    • Inability to take stress
    • Light headedness when standing up from laying down
    • Salt and sugar cravings
    • Increased PMS symptoms
    • Unexplained abdominal weight gain
    • Rashes and skin conditions
    • All inflammatory conditions including cancer
    As the adrenal gland is ultimately the gland that mounts our survival response (“fight or flight”) the body attempts to make up for deficient cortisol by converting hormones such as DHEA, progesterone and testosterone causing further symptoms associated with these hormones including infertility. With adrenal insufficiency comes decreased conversion of T4 to T3, increased reverse T3 which blocks T3 receptors and a dysfunctional thyroid. These conditions are treatable by high dose nutrition, hormone replacement and mind-body interventions.
    As physicians treating this condition, we are faced with the dilemma of many possible effective interventions and little guidance on the priority interventions for the most rapid result. In this lecture, I will share the integration and order of interventions using the 5-point restorative model, through real cases.
    2:05 PM - 3:00 PM
    The Problem of Gynocomastia in Age Management Medicine
    John K. Crisler, D.O.
    President, Founder & CMO, Superior Age Management, AllThingsMale Center for Men's Health, Lansing, MI
    Dept. of Community & Family Medicine, Michigan State University College of Osteopathic Medicine, East Lansing, MI
    Lecture Description:
    Despite the well-proven risks hypogonadism brings to adult males with respect to diabetes, cardiovascular disease, osteoporosis, dementia, depression and sexual dysfunction, etc. about half of all men who begin Testoterone Replacmeent Therapy soon quit. A common reason for this is the onslaught of troubling “nipple issues”; from the development of hypersensitivity, to frank and very unsightly, substantial mammary gland development. The competent TRT physician must know how to properly assess, and treat, gynocomastia in these patients. This is also very important not only for optimizing subjective benefits; “gyno” may serve as a diligent red flag. The usual culprit is estrogen, which, when unbalanced, is clearly implicated in nearly everything that kills a man, outside of trauma. Prolactin, and even Growth Hormone Therapy, also can play deleterious roles. Further—and since so many adult male patients will present with gynocomastia on intake—it is critical to know how to manage this troubling condition. Attendees should understand the Etiology and pathology of gynocomastia, methods of gynocomastia prevention, non-surgical and surgical interventions.
    3:00 PM - 3:30 PM
    Break - Visit Exhibits
    (exhibits close 4:00 PM)
    3:30 PM - 4:20 PM
    The Peptide Revolution: Do We Still Need Hormones?
    Luis Martinez, M.D., MPH
    President, Regenera Global, Ponce, Puerto Rico
    President, XanoGene Clinic, San Juan, Puerto Rico
    Lecture Description:
    Peptides, which are short chains of amino acids, have been shown to exert multiple physiological functions, including modulating gene expression and regulating hormone production. Research on peptides as therapeutic agents has continued to grow, and with it, the promise of improving on current treatments in Age Management Medicine. This talk will look at the latest research on the use of peptides to induce proper organ functioning and thus obtain improved endogenous hormone production. We will examine whether peptide therapy can substitute current Bio-Identical Hormone Replacement protocols. Cases and protocols will be discussed.
    4:00 PM - 4:00 PM
    Exhibits Close
    4:20 PM - 5:30 PM
    Diabetes 3 (Alzheimer’s Disease): The Role of Insulin Resistance and Alzheimer’s Disease
    Edwin N. Lee, M.D., FACE
    Assistant Professor of Internal Medicine, University of Central Florida College of Medicine, Orlando, FL
    Founder, Institute for Hormonal Balance
    Member, AMMG Conference Planning Committee
    Lecture Description:
    Alzheimer’s is the most common form of dementia and usually affects people over the age of 65 years old. Although it accounts for about 70% of dementia in the elderly this disease is not a normal part of aging. In fact there is a subset Alzheimer’s of younger-onset that can appear in the 40-year-olds. Although the exact cause of Alzheimer’s is not known the current medical literature suggests that insulin resistance is a major risk of developing Alzheimer’s. Alzheimer’s is now dubbed as type 3 Diabetes. Other etiologies of developing Alzheimer’s disease will be covered. A review of insulin resistance and the insulin pathway of the PI3K (Phosphoinositide 3 kinase) and the MAPK (Mitogen Activated Protein Kinase) will be discussed in the role of accumulation of neurofibrillary tangles. In addition the Apolipoprotein E-4 will be covered in the production of beta amyloid. The role of environmental toxins and also the role of nitric oxide in Alzheimer’s will be reviewed.



  • Track 1
  • Track 2
  • Friday
  • Saturday
  • Sunday
  •  

    Sunday, April 27th General Session Curriculum
    8:00 AM - 9:00 AM
    The Secret Female Hormone: How Testosterone Replacement Can Change the Life of Female Patients
    Kathy C. Maupin, M.D., FACOG
    Owner & President, BioBalance Health, St. Louis, MO
    Lecture Description:
    Dr. Maupin reveals the critical factors for treating women over 40 with bio-identical testosterone. She will explain the indications and symptomatology that makes up testosterone deficiency in women as they age, as well as the diseases of aging that are prevented by replacing testosterone. Diagnostic laboratory values, physical changes and patient complaints are the triad of diagnosing this deficiency. Dr. Maupin experienced all the symptoms of testosterone deficiency and estradiol loss after a TAH-BSO, and personally understands the implications of testosterone deficiency, and how important it is to replace testosterone. Key target blood levels, comparison of the delivery systems of bio-identical testosterone, as well as risks and benefits, and cost benefit ratios will be delineated and discussed. Most importantly her 12 years of experience with thousands of female testosterone deficient patients provide a wealth of experience in troubleshooting that she will share in her presentation.
    9:00 AM - 10:00 AM
    Multiple Endocrinopathy Syndrome: Concentration on Thyroid, Adrenal and Gonadal Diagnosis and Treatment
    David S. Klein, M.D., FACA, FACPM
    Associate Professor of Medicine, University of Central Florida College of Medicine, Orlando, FL
    Founder and Director, Stages of Life Medical Institute, Longwood, FL
    Lecture Description:
    In this lecture, we will discuss the presentation of Thyroid, Adrenal and Gonadal dysfunction, with emphasis on laboratory diagnosis and subtleties of treatment. Thyroid, adrenal and gonadal function occur simultaneously in a large number of patients. Diagnosis, however, is often incomplete due to complacence or oversight. Focusing on the overlap in complaints, signs and symptoms of these endocrinopathies, emphasis will be placed on therapeutic response and laboratory findings. Treatment approaches will be discussed, including bio-identical hormone replacement, nutritional and dietary intervention. The course objective is to provide a diagnostic and therapeutic framework upon which the participant can approach an otherwise complex clinical problem.
    10:00 AM - 10:15 AM
    Break
    10:15 AM - 11:00 AM
    The Role of Myostatin Inhibition in Sarcopenia
    George C. Shapiro, M.D., FACC
    Adjunct Assistant Professor Clinical Medicine, New York Medical College, Valhalla, NY
    Founding Partner, Cenegenics, New York City
    Member, AMMG Conference Planning Committee
    Robert J. Hariri, M.D., Ph.D.
    Adjunct Associate Professor of Pathology, Mt. Sinai School of Medicine, New York, NY
    Founder and Executive Chairman, MYOS Corporation, Cedar Knolls, NJ
    Co-Founder and Vice-Chairman, Human Longevity, Inc., San Diego, CA
    Founder and Chairman, Celgene Cellular Therapeutics, Summit, NJ
    Louis J. Aronne, M.D., FACP
    Sanford I. Weill Professor of Metabolic Research, Weill-Cornell Medical College, New York, NY
    Board of Directors, MYOS Corporation, Cedar Knolls, NJ
    Lecture Description:
    Virtually all prescribed medications affect metabolism. Some act through cellular receptors on cells, such as neurons, while others alter hormone secretion by gut, pancreas, liver, and fat cells. Clinicians rarely factor these effects into a prescription, especially when the changes are slow, subtle, and will not affect that clinician’s care (i.e. an orthopedic using cortisone injections in a diabetic). It is vital for both clinicians and patients to be informed and proactive in medication choice. Sarcopenia is a loss of skeletal muscle mass and function that occurs in the aging process. Individuals begin to lose muscle mass starting in their thirties and the rate of loss increases with age. Sarcopenia leads to disability and poor quality of life. Nutrition, exercise and hormones contribute to the development of sarcopenia. Myostatin, a negative regulator of muscle growth, is now emerging as a critical factor in muscle physiology. This protein, also known as growth differentiation factor 8 (GDF-8), inhibits pathways leading to the proliferation and differentiation of developing myocytes in myogenesis. Myostatin levels increase with age and have been shown to increase due to other exogenous factors, including the use of testosterone in human males. A bio nutritional supplement composed of a complex mixture of proteins, lipids, peptides and other bioactive molecules has been shown to decrease myostatin levels by 30%. Addressing myostatin levels is one part of a multifactorial approach to improve muscle health. As a therapeutic target, myostatin inhibition is a promising mechanism to combat sarcopenia, age-related muscle loss and loss of muscle regenerative capacity.
    11:00 AM - 12:00 PM
    Bone Density Reconditioning with Osteogenic Loading
    John Jaquish, Ph.D.
    Chief Science & Technology Officer, Performance Health Systems, LLC, Northbrook, IL
    Lecture Description:
    Forces that briefly bend or compress bones stimulate an adaptive response of bone density growth (Wolff, 1892, U.S. Surgeon General, 2004). The bioDensity system allows individuals to self-compress bone, at multiples-of-bodyweight in identified optimal positions, for safety, comfort, and effectiveness (Mookerjee & Ratamess, 1999). An analysis published in Osteoporosis International resulted in increases in bone density from the use of osteogenic loading aparatus (Jaquish, 2013). Analysis of 14 test subjects, average age of 62.5 years, underwent osteogenic loading treatment on a weekly to bi-monthly basis for an average of one year. As subjects engage osteogenic loading use, their ability to produce force/loading increases. As greater bone density develops, subjects can apply greater forces compounding the adaptation from one session to the next. Subjects in a separate bioDensity study increased force production, on average, 6.1% for females and 5.1% for males (Smith, et al. 2013). Subjects achieved an average of 3.1 multiples-of-bodyweight in spinal loading, and an average of 9.2 multiples-of-bodyweight in the legs/hips. Results: The bone density (g/cm2) measures in the subjects increased an average of 7.02% in the hip and 7.73% in the spine. Bone density increases reached statistical significance from pre to post DXA scans (bone density analysis X-rays) ANOVA (P < 0.001). This indicates that osteogenic loading can have significant effect on bone density, and can be used in a comprehensive program for prevention of fragility fractures.
    12:00 PM - 1:30 PM
    Clinical Case Presentations in Age Management Medicine
    Florence Comite, M.D.
    CEO & Founder, Comite Center for Precision Medicine, New York, NY
    Member, AMMG Conference Planning Committee
    Derrick M. DeSilva, Jr., M.D.
    Chairman, AMMG Conference Planning Committee
    Senior Attending Staff, Dept. of Medicine, Raritan Bay Medical Center, Perth Amboy, NJ
    Teaching Faculty, JFK Medical Center, Edison, NJ
    George C. Shapiro, M.D., FACC
    Adjunct Assistant Professor Clinical Medicine, New York Medical College, Valhalla, NY
    Founding Partner, Cenegenics, New York City
    Member, AMMG Conference Planning Committee
    Edwin N. Lee, M.D., FACE
    Assistant Professor of Internal Medicine, University of Central Florida College of Medicine, Orlando, FL
    Founder, Institute for Hormonal Balance
    Member, AMMG Conference Planning Committee



  • Track 1
  • Track 2
  • Friday
  • Saturday
  • Sunday
  • Age Management Medicine Conference 2018 Orlando - Integrative Metabolic & Functional CME Medical TrainingAge Management Medicine Conference 2018 Orlando - Integrative Metabolic & Functional CME Medical Training

     

    Conference Videos


     

    BACK TO AMMG HOME

    MAILING ADDRESS

    1534 Serrano Circle
    Naples, FL 34105

    CONTACT US

    Phone: (239) 330-7495
    Email: conference@agemed.org

    Home  |  About Us  |  Contact Us   |  

    Privacy Statement   |  Terms Of Use   |  Copyright 2018 by Age Management Medicine Group   |  Login